Notices to creditors (MVL)
AMRYT PHARMA (UK) LIMITED
The notice informs creditors of AMRYT PHARMA (UK) LIMITED that, as part of its voluntary winding‑up, they must submit proofs of debt by 14 August 2026 to the joint liquidators.
Notice details
- Company
- AMRYT PHARMA (UK) LIMITED
- Company number
- 10463152
- Registered office
- C/O Corporation Service Company (UK) Limited, 5 Churchill Place, 10th Floor, London E14 5HU
- Principal trading address
- C/O Corporation Service Company (UK) Limited, 5 Churchill Place, 10th Floor, London E14 5HU
- Type of liquidation
- Voluntary winding up (MVL)
- Date of appointment
- 9 July 2026
- Office holder(s)/Liquidator(s)
- James Hawksworth (IP No. 22450); Terence Guy Jackson (IP No. 16450)
- Contact
- Harry Short, RSM UK Restructuring Advisory LLP, 25 Farringdon Street, London EC4A 4AB, Tel: 020 3201 8000, Email: [email protected]
Planning a solvent wind-down or restructure?
A members' voluntary liquidation is a solvent, orderly closure — often part of retirement, a group restructure, or moving on to the next venture. K2 has advised UK company directors since 1990 on restructuring and what comes next. If that's on your horizon, talk to us.
Related guidance
Free, practical guides from K2 on what this kind of notice means for directors.
More liquidation notices
Source: The London Gazette and Companies House. Contains public sector information licensed under the Open Government Licence v3.0. © Crown copyright. This page is provided by K2 Partners for information only and is not legal or financial advice.